Discovery and Evaluation of Novel Anti-inflammatory Derivatives of Natural Bioactive Curcumin
Overview
Authors
Affiliations
Curcumin is a natural active product that has various pharmacological activities such as anti-inflammatory effects. Here, we report the synthesis and evaluation of 34 monocarbonyl curcumin analogs as novel anti-inflammatory agents. Among the analogs, the symmetrical heterocyclic type displayed the strongest inhibition of lipopolysaccharide (LPS)-stimulated expression of pro-inflammatory cytokines in macrophages. Analogs S1-S5 and AS29 reduced tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) production in a dose-dependent manner and also displayed excellent stability and low cytotoxicity in vitro. In addition, analog S1 dose-dependently inhibited LPS-induced extracellular signal-regulated kinase (ERK) phosphorylation. Furthermore, analogs S1 and S4 displayed a significant protective effect on LPS-induced septic death in mouse models, with 40% and 50% survival rates, respectively. These data demonstrate that the heterocyclic monocarbonyl curcumin analogs have potential therapeutic effects in acute inflammatory diseases.
Moreira J, Saraiva L, Pinto M, Cidade H Molecules. 2022; 27(19).
PMID: 36234878 PMC: 9572019. DOI: 10.3390/molecules27196340.
Improved Synthesis of Asymmetric Curcuminoids and Their Assessment as Antioxidants.
Cheng Y, Li C, Kuo C, Shih T, Chen J Molecules. 2022; 27(8).
PMID: 35458741 PMC: 9030899. DOI: 10.3390/molecules27082547.
Gong X, Jiang L, Li W, Liang Q, Li Z Bioengineered. 2021; 12(1):5017-5027.
PMID: 34402718 PMC: 8806675. DOI: 10.1080/21655979.2021.1960765.
Pastor N, Collado M, Manzoni P Nutrients. 2021; 13(2).
PMID: 33573173 PMC: 7910826. DOI: 10.3390/nu13020464.
Prasetyaningrum P, Bahtiar A, Hayun H Sci Pharm. 2018; 86(2).
PMID: 29880783 PMC: 6027665. DOI: 10.3390/scipharm86020025.